Early research (Phase 1)Ended earlyNCT06430905
What this trial is testing
Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART
Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Hookipa Biotech GmbH 30